Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01422473 · ClinicalTrials.gov registry record · NA
Comparison Study of Hemorrhoid Surgery Using the Enseal Device to Standard Hemorrhoid Surgical Techniques
A NA study, sponsored by Swedish Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT01422473 is a NA study that was terminated before completion, run by Swedish Medical Center. The registered enrollment target is 9 participants.
The verdict
NCT01422473, a NA study, was terminated before completion, sponsored by Swedish Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the advantages and disadvantages of using the EnSeal device in hemorrhoid surgery as compared to traditional hemorrhoid surgery techniques. It is hypothesized that the use of the Enseal device will demonstrate an improvement a patient's overall experience through less postoperative bleeding and pain, decreased time for wound healing, and a faster return to work.
Interventions
- DEVICE EnSeal Trio Tissue Sealing Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2011-08 |
| Est. Completion | 2013-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01422473
The ClinicalTrials.gov registry entry for NCT01422473 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Swedish Medical Center, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which EnSeal Trio Tissue Sealing Device is the first listed.
NCT01422473 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01422473 about?
NCT01422473 is a clinical study titled "Comparison Study of Hemorrhoid Surgery Using the Enseal Device to Standard Hemorrhoid Surgical Techniques". The purpose of this study is to examine the advantages and disadvantages of using the EnSeal device in hemorrhoid surgery as compared to traditional hemorrhoid surgery techniques. It is hypothesized that the use of the Enseal device will demonstrate an improvement a patient's overall experience thr...
What is the current status of trial NCT01422473?
This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2011-08. Estimated completion is 2013-01.
What interventions are being tested in trial NCT01422473?
The interventions under investigation include: EnSeal Trio Tissue Sealing Device (DEVICE).
Who is sponsoring clinical trial NCT01422473?
This trial is sponsored by Swedish Medical Center, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.